Evidence map›Paper›PMID 30508141›Full record

Trial reportTranslational behavioral medicine2020

Feasibility of implementing mobile technology-delivered mental health treatment in routine adult sickle cell disease care.

Charles R Jonassaint, Chaeryon Kang, Kemar V Prussien, Janet Yarboi, Maureen S Sanger, J Deanna Wilson, Laura De Castro, Nirmish Shah, Urmimala Sarkar

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational behavioral medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Digital behavioural interventions for people with sickle cell disease.The Cochrane database of systematic reviews · 2021
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Charles R JonassaintDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Chaeryon KangDepartment of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
Kemar V PrussienDepartment of Psychology and Human Development, Vanderbilt University, Nashville, TN, USA.
Janet YarboiDepartment of Psychology and Human Development, Vanderbilt University, Nashville, TN, USA.
Maureen S SangerDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
J Deanna WilsonDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Laura De CastroDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Nirmish ShahDepartment of Medicine, Duke University, Durham, NC, USA.
Urmimala SarkarUCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, University of California, San Francisco, CA, USA.

Funding

LIFE-SPAN DEVELOPMENT OF NORMAL AND ABNORMAL BEHAVIORT32MH018921 · NIMH · VANDERBILT UNIVERSITY · PI HUMPHREYS, KATHRYN LEIGH · 1989 to 2024
$6.7M
Using Technology to Deliver Evidence-Based Interventions for Pain to Patients with Sickle Cell DiseaseK23HL135396 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JONASSAINT, CHARLES RICHARD · 2017 to 2020
$597k
AHRQ HHS K12 HS022989NHLBI NIH HHS K23 HL135396NIMH NIH HHS T32 MH018921
6 · The paper itself

Abstract

Sickle cell disease (SCD) is a severe hemoglobinopathy characterized by acute and chronic pain. Sufferers of the disease, most of whom are underrepresented minorities, are at increased risk for mental health disorders. The purpose of this study is to test the acceptability and implementation of a computerized cognitive behavioral therapy (cCBT) intervention, Beating the Blues, to improve depression, anxiety, and pain in patients with SCD. Adults with SCD and significant symptoms of depression (Patient Health Questionnaire [PHQ-9] score ≥ 10) or anxiety (Generalized Anxiety Disorder Scale [GAD-7] score ≥ 10) were eligible to participate and be randomized to either receive eight sessions of cCBT with care coach support or treatment as usual. Participants reported daily pain and mood symptoms using a mobile diary app. Depression, anxiety, and pain symptoms were assessed at 1, 3, and 6 months. Thirty patients were enrolled: 18 to cCBT, and 12 to control. The cCBT intervention was feasible to implement in clinical settings and acceptable to participants. Patients in the cCBT arm reported a marginally greater decrease in depression at 6 months (-3.82, SE = 1.30) than those in the control group (-0.50, SE = 1.60; p = .06). There were no significant effects of treatment on anxiety; however, cCBT was associated with improved daily pain reported via a mobile diary app (p = .014). cCBT, delivered via mobile device, is a feasible strategy to provide mental health care to adults living with SCD. cCBT was acceptable to the target population; was able to be implemented in real-world, nonideal conditions; and has the potential to improve patient-reported outcomes.

Indexed as

Anemia, Sickle CellMental HealthAdultAnxiety DisordersFeasibility StudiesHumansTechnologyCognitive behavioral therapyDepressionHealth information technologyMental healthSickle cell disease

Identifiers

PMID30508141
PMCPMC7295699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.